BioEdge Research Labs Expands Independent Analytical Testing Program

US-based research peptide supplier broadens third-party analytical testing and per-batch Certificate of Analysis documentation across its research product line. All products are sold for laboratory research use only.

WILMINGTON, DE / ACCESS Newswire / September 4, 2026 / BioEdge Research Labs, a United States-based supplier of research peptides and reference materials, today announced an expansion of its independent analytical testing program. The expanded program broadens the analytical testing and batch-level documentation that accompany the company's research-use-only materials, reinforcing an approach built on verifiable, laboratory-grade documentation.

Independent analytical testing and verifiable records have become central to how laboratory and research customers evaluate research-grade materials. Rather than relying on a supplier's description alone, researchers increasingly expect documentation they can review and confirm for the specific material they receive. BioEdge's program is built around third-party analysis and a batch-specific Certificate of Analysis (COA) for every lot, giving researchers analytical records to review both before and after purchase.

Third-Party Analytical Testing

Under the expanded program, BioEdge research materials are analyzed by an independent third-party laboratory. Testing covers identity and purity by established analytical methods, including high-performance liquid chromatography (HPLC) for purity and mass spectrometry (MS) for identity confirmation, alongside contaminant screening. Reporting each result on a Certificate of Analysis tied to the specific batch allows a researcher to see the underlying analytical data, not only a summary figure.

A Certificate of Analysis for Every Lot

Each vial carries a lot number that corresponds to its own Certificate of Analysis, rather than a single certificate carried forward across multiple production runs. Because analytical results can vary from one batch to the next, per-lot documentation is what allows a researcher to match the record to the material actually in hand. Batch-specific COAs are made available on the company's product pages, and each lot number is intended to correspond to the documentation for that batch.

Documentation and Transparency

The expanded program reflects a broader emphasis on transparency in the research materials market. By centering the process on independent analysis and accessible, batch-level records, BioEdge aims to give qualified researchers a clear basis for evaluating identity, purity, and analytical documentation across the product line.

Research Use Only

All materials supplied by BioEdge Research Labs are sold strictly for laboratory research and in vitro use by qualified researchers and scientific professionals. They are not drugs, supplements, or medical products.

About BioEdge Research Labs

BioEdge Research Labs is a United States-based supplier of research peptides and reference materials serving laboratory and research customers. The company provides research-grade materials supported by independent third-party analytical testing and batch-specific Certificates of Analysis. Learn more at https://thebioedgeresearchlabs.com.

Media Contact
1842 Marketstone Avenue, Suite 410
Wilmington, DE 19801
(302) 757-0147
[email protected]

All products sold by BioEdge Research Labs are intended strictly for laboratory research and in vitro use by qualified researchers and scientific professionals. These products are not intended to diagnose, treat, cure, or prevent any disease, are not intended to affect the structure or any function of the body, and are not intended for human or veterinary use, consumption, or self-administration. They have not been evaluated or approved by the U.S. Food and Drug Administration for diagnostic, therapeutic, or preventative purposes. BioEdge Research Labs is a chemical supplier and is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no therapeutic claims.

SOURCE: The BioEdge Research Labs

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Northrop Grumman wins $508M missile defense contract
• Epic Gold plans $3.15M non-brokered private placement